Autres langues Delcath Systems, Inc.

Actions

DCTH

US24661P8077

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
5,71 ^USD	+2,70 %		+2,70 %	+37,26 %

06/05	Delcath Systems annonce que les données de l'étude de phase 3 sur le Hepzato Kit sont publiées dans une revue d'oncologie	MT
06/05	Delcath Systems, Inc. annonce la publication des résultats de l'étude pivotale FOCUS chez les patients atteints de mélanome uvéal métastatique traités par HEPZATO KIT	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Delcath Systems to Host First Quarter 2024 Earnings Call	07/05
Delcath Systems Says Phase 3 Data on Hepzato Kit Published in Oncology Journal	06/05
Delcath Systems, Inc Announces Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT	06/05
Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	03/05
Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride	26/04
Delcath : Material Agreement - Form 8-K	26/04
Delcath Announces Inducement Grant under Nasdaq Listing Rule 5635(4)	05/04
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	04/04
Earnings Flash (DCTH) DELCATH SYSTEMS Reports Q4 Revenue $539,000, vs. Street Est of $550,000	26/03
Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update	26/03
Delcath Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Delcath Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/03
North American Morning Briefing : Markets Steady -2-	26/03
Delcath Systems Closes $7 Million Private Placement	20/03
Delcath Systems, Inc. announced that it has received $7.00111 million in funding	20/03
Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call	19/03
Delcath Systems Names Chief Operating Officer	19/03
Delcath Systems Appoints Martha S. Rook as Chief Operating Officer	18/03
Delcath Systems, Inc. Appoints Martha S. Rook as Chief Operating Officer	18/03
Delcath Systems Announces $7 Million Private Placement	15/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Delcath Systems, Inc.

Actions

DCTH

US24661P8077

Autres langues

Filtres